illustration with scales showing the balance between efficacy and toxicity in CAR T-cell therapy
21 October 2024
CAR T-cell therapy in oncology: The road ahead

  CAR T-cell therapy has emerged as a ground-breaking advancement in the treatment of cancer, offering hope to patients with certain types of cancers that are resistant to more conventional therapies. By genetically modifying a patient’s own T cells to recognise and attack cancer cells, this immunotherapy has demonstrated remarkable success, leading to long-term remissions …

Continue reading “CAR T-cell therapy in oncology: The road ahead”